Transferring ARMin to the Clinics and Industry.

Autor: Riener, Robert, Guidali, Marco, Keller, Urs, Duschau-Wicke, Alexander, Klamroth, Verena, Nef, Tobias
Zdroj: Topics in Spinal Cord Injury Rehabilitation; Summer2011, Vol. 17 Issue 1, p54-59, 6p
Abstrakt: In the last few years, novel robotic technology has been developed that has the potential to improve upper extremity function after spinal cord injury (SCI), stroke, and other neurological diseases. Three generations of the arm therapy robot ARMin were developed and clinically evaluated on many patients. Key focus was on the training of functional tasks incorporating activities of daily living (ADL) with large range of motion of the entire arm in order to enhance transfer to daily life and improve quality of life. Encouraged by the promising results in first single-case studies performed with ARMin I and ARMin II, an optimized ARMin III was developed and duplicated and is currently being used within a 4-center randomized clinical trial. A fourth generation of ARMin is currently under development that will have further functional benefits with respect to patient-cooperative control and therapy assessment. Intellectual property has been identified for technology transfer and commercial exploitation. The continuation of the clinical research and the future product development and commercialization may satisfy the pressing socioeconomic need to improve quality of life of the disabled subjects. [ABSTRACT FROM AUTHOR]
Databáze: Supplemental Index